PCV71 COST-EFFECTIVENESS OF EZETIMIBE/SIMVASTATIN VERSUS SIMVASTATIN: WILL THE INCREASED RISK OF CANCER MAKE EZETIMIBE/SIMVASTATIN AN INAPPROPRIATE TREATMENT CHOICE?

• 作者CC Wang; AK Biddle; JF Farley
• 卷第12卷
• 期第3期
• 文件大小88.75KB
• 发表时间2009
• DOI10.1016/s1098-3015(10)73832-8